<div id="readability-page-1"><div><p>Fujian Wanchen Biotechnology Group Co.,Ltd. reported earnings results for the nine months ended September 30, 2025. For the nine months, the company reported sales was CNY 36,562.31 million compared to CNY 20,613.1 million a year ago. Net income was CNY 854.98 million compared to CNY 84.07 million a year ago.</p><p>Basic earnings per share from continuing operations was CNY 4.684 compared to CNY 0.5001 a year ago. Diluted earnings per share from continuing operations was CNY 4.3431 compared to CNY 0.4647 a year ago.</p></div></div>

萬辰集團

<p>福建萬辰生物科技集團有限公司公佈了截至 2025 年 9 月 30 日的九個月財報。該公司在這九個月內的銷售額為 365.6231 億元人民幣，而去年同期為 206.131 億元人民幣。淨收入為 8.5498 億元人民幣，而去年同期為 8407 萬元人民幣。來自持續經營的基本每股收益為 4.684 元人民幣，而去年同期為 0.5001 元人民幣。來自持續經營的攤薄每股收益為 4.3431 元人民幣，而去年同期為 0.4647 元人民幣</p>

福建萬辰生物科技集團有限公司公佈了截至2025年9月30日的九個月財務業績